Global Early Cancer Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR102412255

Publication Date:

October 22, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Early Cancer Detection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Body fluid samples were collected for early cancer detection, and CTC, ctDNA and other markers were captured to evaluate the tumor situation. It is non-invasive, efficient, sensitive and highly acceptable for patients.
The early cancer detection market is a rapidly evolving sector within the healthcare industry. Early detection of cancer is crucial for improving treatment outcomes and reducing mortality rates. Detecting cancer at an earlier stage allows for more effective treatment options and increases the chances of successful recovery.
Various screening technologies are used for early cancer detection, including imaging techniques like mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear for cervical cancer, and PSA blood test for prostate cancer. These screening methods have been widely adopted and are proven to be effective in detecting cancer at an early stage.
Thepublisher report includes an overview of the development of the Early Cancer Detection industry chain, the market status of Hospital (ctDNA, CTC), Clinic (ctDNA, CTC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Early Cancer Detection.
Regionally, the report analyzes the Early Cancer Detection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Early Cancer Detection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Early Cancer Detection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Early Cancer Detection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., ctDNA, CTC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Early Cancer Detection market.
Regional Analysis: The report involves examining the Early Cancer Detection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Early Cancer Detection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Early Cancer Detection:
Company Analysis: Report covers individual Early Cancer Detection players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Early Cancer Detection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Early Cancer Detection. It assesses the current state, advancements, and potential future developments in Early Cancer Detection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Early Cancer Detection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Early Cancer Detection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
ctDNA
CTC
Exosomes
Circulating protein
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
GRAIL(Illumina)
Exact Sciences
Guardant Health
BGI
New Horizon Health
Epigenomics AG
Genetron Health
Berry Genomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Early Cancer Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Early Cancer Detection, with revenue, gross margin and global market share of Early Cancer Detection from 2019 to 2024.
Chapter 3, the Early Cancer Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Early Cancer Detection market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Early Cancer Detection.
Chapter 13, to describe Early Cancer Detection research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Early Cancer Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Early Cancer Detection by Type
1.3.1 Overview: Global Early Cancer Detection Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Early Cancer Detection Consumption Value Market Share by Type in 2023
1.3.3 ctDNA
1.3.4 CTC
1.3.5 Exosomes
1.3.6 Circulating protein
1.4 Global Early Cancer Detection Market by Application
1.4.1 Overview: Global Early Cancer Detection Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Early Cancer Detection Market Size & Forecast
1.6 Global Early Cancer Detection Market Size and Forecast by Region
1.6.1 Global Early Cancer Detection Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Early Cancer Detection Market Size by Region, (2019-2030)
1.6.3 North America Early Cancer Detection Market Size and Prospect (2019-2030)
1.6.4 Europe Early Cancer Detection Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Early Cancer Detection Market Size and Prospect (2019-2030)
1.6.6 South America Early Cancer Detection Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Early Cancer Detection Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 GRAIL(Illumina)
2.1.1 GRAIL(Illumina) Details
2.1.2 GRAIL(Illumina) Major Business
2.1.3 GRAIL(Illumina) Early Cancer Detection Product and Solutions
2.1.4 GRAIL(Illumina) Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GRAIL(Illumina) Recent Developments and Future Plans
2.2 Exact Sciences
2.2.1 Exact Sciences Details
2.2.2 Exact Sciences Major Business
2.2.3 Exact Sciences Early Cancer Detection Product and Solutions
2.2.4 Exact Sciences Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Exact Sciences Recent Developments and Future Plans
2.3 Guardant Health
2.3.1 Guardant Health Details
2.3.2 Guardant Health Major Business
2.3.3 Guardant Health Early Cancer Detection Product and Solutions
2.3.4 Guardant Health Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Guardant Health Recent Developments and Future Plans
2.4 BGI
2.4.1 BGI Details
2.4.2 BGI Major Business
2.4.3 BGI Early Cancer Detection Product and Solutions
2.4.4 BGI Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 BGI Recent Developments and Future Plans
2.5 New Horizon Health
2.5.1 New Horizon Health Details
2.5.2 New Horizon Health Major Business
2.5.3 New Horizon Health Early Cancer Detection Product and Solutions
2.5.4 New Horizon Health Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 New Horizon Health Recent Developments and Future Plans
2.6 Epigenomics AG
2.6.1 Epigenomics AG Details
2.6.2 Epigenomics AG Major Business
2.6.3 Epigenomics AG Early Cancer Detection Product and Solutions
2.6.4 Epigenomics AG Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Epigenomics AG Recent Developments and Future Plans
2.7 Genetron Health
2.7.1 Genetron Health Details
2.7.2 Genetron Health Major Business
2.7.3 Genetron Health Early Cancer Detection Product and Solutions
2.7.4 Genetron Health Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Genetron Health Recent Developments and Future Plans
2.8 Berry Genomics
2.8.1 Berry Genomics Details
2.8.2 Berry Genomics Major Business
2.8.3 Berry Genomics Early Cancer Detection Product and Solutions
2.8.4 Berry Genomics Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Berry Genomics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Early Cancer Detection Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Early Cancer Detection by Company Revenue
3.2.2 Top 3 Early Cancer Detection Players Market Share in 2023
3.2.3 Top 6 Early Cancer Detection Players Market Share in 2023
3.3 Early Cancer Detection Market: Overall Company Footprint Analysis
3.3.1 Early Cancer Detection Market: Region Footprint
3.3.2 Early Cancer Detection Market: Company Product Type Footprint
3.3.3 Early Cancer Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Early Cancer Detection Consumption Value and Market Share by Type (2019-2024)
4.2 Global Early Cancer Detection Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Early Cancer Detection Consumption Value Market Share by Application (2019-2024)
5.2 Global Early Cancer Detection Market Forecast by Application (2025-2030)
6 North America
6.1 North America Early Cancer Detection Consumption Value by Type (2019-2030)
6.2 North America Early Cancer Detection Consumption Value by Application (2019-2030)
6.3 North America Early Cancer Detection Market Size by Country
6.3.1 North America Early Cancer Detection Consumption Value by Country (2019-2030)
6.3.2 United States Early Cancer Detection Market Size and Forecast (2019-2030)
6.3.3 Canada Early Cancer Detection Market Size and Forecast (2019-2030)
6.3.4 Mexico Early Cancer Detection Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Early Cancer Detection Consumption Value by Type (2019-2030)
7.2 Europe Early Cancer Detection Consumption Value by Application (2019-2030)
7.3 Europe Early Cancer Detection Market Size by Country
7.3.1 Europe Early Cancer Detection Consumption Value by Country (2019-2030)
7.3.2 Germany Early Cancer Detection Market Size and Forecast (2019-2030)
7.3.3 France Early Cancer Detection Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Early Cancer Detection Market Size and Forecast (2019-2030)
7.3.5 Russia Early Cancer Detection Market Size and Forecast (2019-2030)
7.3.6 Italy Early Cancer Detection Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Early Cancer Detection Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Early Cancer Detection Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Early Cancer Detection Market Size by Region
8.3.1 Asia-Pacific Early Cancer Detection Consumption Value by Region (2019-2030)
8.3.2 China Early Cancer Detection Market Size and Forecast (2019-2030)
8.3.3 Japan Early Cancer Detection Market Size and Forecast (2019-2030)
8.3.4 South Korea Early Cancer Detection Market Size and Forecast (2019-2030)
8.3.5 India Early Cancer Detection Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Early Cancer Detection Market Size and Forecast (2019-2030)
8.3.7 Australia Early Cancer Detection Market Size and Forecast (2019-2030)
9 South America
9.1 South America Early Cancer Detection Consumption Value by Type (2019-2030)
9.2 South America Early Cancer Detection Consumption Value by Application (2019-2030)
9.3 South America Early Cancer Detection Market Size by Country
9.3.1 South America Early Cancer Detection Consumption Value by Country (2019-2030)
9.3.2 Brazil Early Cancer Detection Market Size and Forecast (2019-2030)
9.3.3 Argentina Early Cancer Detection Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Early Cancer Detection Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Early Cancer Detection Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Early Cancer Detection Market Size by Country
10.3.1 Middle East & Africa Early Cancer Detection Consumption Value by Country (2019-2030)
10.3.2 Turkey Early Cancer Detection Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Early Cancer Detection Market Size and Forecast (2019-2030)
10.3.4 UAE Early Cancer Detection Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Early Cancer Detection Market Drivers
11.2 Early Cancer Detection Market Restraints
11.3 Early Cancer Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Early Cancer Detection Industry Chain
12.2 Early Cancer Detection Upstream Analysis
12.3 Early Cancer Detection Midstream Analysis
12.4 Early Cancer Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

GRAIL(Illumina)
Exact Sciences
Guardant Health
BGI
New Horizon Health
Epigenomics AG
Genetron Health
Berry Genomics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂